Is Viagra Good for Men With Type 2 Diabetes?

Sildenafil, the drug sold as Viagra, is broadly effective for erectile dysfunction in men with type 2 diabetes, though it tends to work somewhat less well for them than for men without diabetes. The reason traces to the specific vascular and nerve damage that high blood sugar inflicts on the tissue responsible for erections. What makes the question more interesting than a simple yes-or-no is a growing body of research suggesting that sildenafil may offer men with type 2 diabetes benefits that go well beyond the bedroom, including improvements in blood-vessel health and possibly even insulin sensitivity.

Why Erectile Dysfunction Is So Common in Type 2 Diabetes

Erectile dysfunction affects men with diabetes at roughly three and a half times the rate seen in men without diabetes, and it often shows up earlier in life and with greater severity.¹ The reasons are layered but center on what chronically elevated blood sugar does to the inner lining of blood vessels, particularly the small ones that supply the penis.

An erection depends on a chemical cascade that relaxes smooth muscle in penile tissue and lets blood rush in. The key molecule driving that relaxation is nitric oxide, released by the endothelial cells that line blood vessels. In men with type 2 diabetes, long-term high glucose promotes the buildup of advanced glycation end-products, which reduce the amount of nitric oxide available and ramp up oxidative stress inside those cells. The enzyme responsible for producing nitric oxide is often less active in these men, meaning the signal to relax penile smooth muscle is weaker from the start.²

On top of the vascular damage, diabetes frequently causes peripheral neuropathy, meaning the nerves that trigger an erection may be impaired as well. The combination of weakened blood-vessel signals and damaged nerves is why diabetic ED tends to be more stubborn than the garden-variety version. It also explains why the response to sildenafil, while real, is often not as robust as in men without diabetes.

How Well Sildenafil Works for Diabetic ED

Sildenafil works by blocking an enzyme called PDE5 that breaks down a molecule involved in keeping penile smooth muscle relaxed. By slowing that breakdown, the drug amplifies whatever nitric oxide signal is already there. The catch for men with diabetes is that their baseline nitric oxide signal is diminished, so there is less to amplify.

In a randomized controlled trial published in JAMA, men with diabetes who took sildenafil showed clear improvement in erectile function compared to placebo, but their scores on standard questionnaires were lower than those reported in earlier studies of men with ED from mixed causes. The investigators noted that baseline erectile function was also worse in the diabetic group, pointing to greater underlying severity of the condition.³ A separate study comparing diabetic and non-diabetic men directly found that overall satisfaction and self-reported success rates were significantly higher in the non-diabetic group.⁴

None of this means sildenafil doesn’t help. It does, and for many men with type 2 diabetes it is the difference between functional erections and none at all. Across the broader population of men with ED from all causes, on-demand PDE5 inhibitors like sildenafil have an overall success rate in the range of 60 to 70 percent.⁵ For men with diabetes specifically, the rate tends to sit at the lower end of that range or slightly below it. The drug still works; it just has less raw material to work with.

There May Also Be Another Mechanism at Play

Research on penile tissue samples from men with diabetes has uncovered an additional wrinkle. Beyond the well-known nitric oxide pathway, the small arteries that supply the penis also rely on a secondary relaxation signal sometimes called endothelium-derived hyperpolarizing factor. Diabetes appears to impair that backup pathway too. Because sildenafil targets only the nitric oxide side of the equation, damage to this second pathway may partly explain why some men with diabetes get a muted response to the drug, even at higher doses.² This is an area where the science is still catching up, but it helps explain why simply prescribing a higher dose does not always close the gap.

Benefits Beyond Erections

Some of the most intriguing research on sildenafil and type 2 diabetes has nothing to do with sexual function at all. Because PDE5 is found in blood vessels throughout the body, blocking it has systemic vascular effects that turn out to be relevant to several complications of diabetes.

Endothelial Function

Endothelial dysfunction, meaning the blood vessel lining doesn’t relax the way it should, is one of the earliest and most pervasive consequences of type 2 diabetes. It contributes to heart disease, kidney damage, and poor circulation in the extremities. Two separate trials tested what happens when men with type 2 diabetes take sildenafil daily rather than just before sex.

In a four-week trial, men assigned to chronic sildenafil showed a progressive improvement in flow-mediated dilation, a standard measure of how well arteries relax. By the end of the study, flow-mediated dilation had nearly doubled compared to baseline. At the same time, markers of inflammation and endothelial activation dropped significantly.⁶ A longer, ten-week trial found similar results: daily sildenafil significantly improved both erectile rigidity and brachial artery flow-mediated dilation, a measure that reflects the health of the blood-vessel lining throughout the body.⁷

These are small studies, and daily use of sildenafil for vascular protection is not a standard recommendation. But the direction of the evidence is consistent and suggests that the drug’s reach extends well past the penis.

Insulin Sensitivity

A randomized, placebo-controlled trial in people with prediabetes found that three months of sildenafil treatment significantly improved insulin sensitivity, meaning the body’s cells responded better to insulin. The improvement was accompanied by better markers of endothelial function, but there was no detectable change in how the pancreas secreted insulin.⁸ This is an early finding from a single trial, and it was conducted in prediabetic individuals rather than people with established type 2 diabetes, so it does not mean sildenafil should be viewed as a diabetes treatment. Still, it raises the possibility that the drug’s vascular benefits could have meaningful metabolic knock-on effects, something researchers are continuing to explore.

What Animal Studies Show About Nerve and Kidney Damage

Two of the most feared complications of type 2 diabetes are peripheral neuropathy, which causes numbness, tingling, and pain in the hands and feet, and diabetic nephropathy, which can progress to kidney failure. Animal research suggests sildenafil may have protective effects against both, though none of this has been confirmed in human trials yet.

In a study using mice genetically prone to type 2 diabetes, sildenafil treatment increased blood flow in the sciatic nerve, improved motor and sensory nerve conduction speeds, and boosted the density of nerve fibers in the skin. The researchers concluded that the drug’s improvement of neurovascular function likely contributed to better nerve performance.⁹ In diabetic rat models, sildenafil reduced albumin excretion in the urine (a hallmark of kidney damage), attenuated glomerular enlargement, and decreased markers of scarring and inflammation in kidney tissue.¹⁰ ¹¹

These are animal models, so the usual caution applies: effects in mice and rats do not automatically translate to humans. But they are biologically plausible given what we know about how sildenafil works on blood vessels. If the drug can improve microvascular blood flow in the nerves and kidneys of people with diabetes the way it seems to in animals, the clinical implications would stretch far beyond ED. For now, this remains promising but unproven territory in humans.

Safety and the One Big Contraindication

Sildenafil is generally well tolerated in men with type 2 diabetes. In a study of diabetic men, side effects were described as mild and transient.¹² The common complaints are the same ones seen in non-diabetic users: headache, flushing, nasal congestion, and occasionally visual disturbances. These are nuisances, not dangers.

The one scenario where sildenafil becomes genuinely dangerous is when it is combined with nitrate medications. Nitrates, commonly prescribed for angina (chest pain caused by heart disease), include drugs like nitroglycerin and isosorbide mononitrate. Sildenafil and nitrates both lower blood pressure through overlapping mechanisms, and taking them together can cause a severe, potentially fatal drop in blood pressure and coronary blood flow.¹³ ¹⁴ This matters for men with type 2 diabetes because they are at elevated risk for coronary artery disease and may already be taking nitrates. If you use any form of nitrate, sildenafil is off the table, period. This is not a theoretical concern; deaths have been reported.

Men with type 2 diabetes who take blood pressure medications other than nitrates can generally use sildenafil safely, but it is worth discussing the full medication list with a doctor because some combinations can cause mild additional drops in blood pressure, particularly alpha-blockers. The bigger picture is reassuring: sildenafil on its own does not appear to increase heart attack risk in diabetic men, and the endothelial improvements described above suggest it may even be mildly cardioprotective.

When Sildenafil Does Not Work Well Enough

About 30 to 35 percent of men with ED from all causes do not respond adequately to a PDE5 inhibitor on first try. Before giving up, though, roughly 30 to 50 percent of those apparent non-responders can be rescued with better counseling on how to use the drug correctly: taking it on an empty stomach, allowing enough time for it to take effect, and making sure adequate sexual stimulation is present.⁵ This is worth emphasizing because many men conclude too quickly that the drug has failed when the issue is really how they are using it.

For men with type 2 diabetes who still do not respond, testosterone levels are worth investigating. Low testosterone is common in this population, and while one study found that men with normal testosterone and low testosterone responded to sildenafil at similar overall rates, the degree of improvement in the low-testosterone group was significantly correlated with testosterone levels. The investigators suggested that testosterone supplementation in men with low levels may improve their response to sildenafil.¹⁵ So checking and addressing low testosterone before writing off sildenafil is a practical step that is sometimes overlooked.

If sildenafil truly fails after adequate trials and any hormonal issues have been addressed, alternatives include tadalafil (Cialis), which has a longer duration of action and can be taken daily at a low dose, as well as non-oral treatments like penile injections, urethral suppositories, or surgical implants for the most refractory cases.

Daily Dosing Versus On-Demand Use

Most men take sildenafil as needed, about an hour before sexual activity. But the endothelial studies described earlier used daily dosing, and the question of whether a daily regimen offers advantages for men with diabetes is worth considering. A twelve-week randomized trial comparing on-demand sildenafil, on-demand tadalafil, and daily low-dose tadalafil found that the daily tadalafil regimen was superior for improving erectile function, particularly the ability to penetrate, and it also reduced symptoms of depression and anxiety.¹⁶ That trial was not limited to diabetic men, so the findings may not translate directly. But the concept of daily PDE5 inhibitor use aligns well with what we know about the vascular benefits: steady-state drug levels may produce more consistent endothelial support than intermittent peaks and troughs.

Daily sildenafil is not FDA-approved in the way daily tadalafil is, but some physicians prescribe it off-label, particularly when the goal includes vascular benefit alongside erectile improvement. For men with type 2 diabetes, who stand to benefit from both, this is a conversation worth having with a doctor. The cost and commitment of daily medication need to be weighed against the potential for better function and fewer performance-related anxieties around sexual encounters.

How Blood Sugar Control Affects the Drug’s Effectiveness

One point that sometimes gets lost in discussions of pharmacotherapy is that how well sildenafil works for a given man with type 2 diabetes is not fixed. It depends partly on how well his diabetes is controlled. Prolonged hyperglycemia progressively worsens the endothelial damage and neuropathy that limit the drug’s efficacy. Men who bring their blood sugar under tighter control may find that the drug works better over time, because there is more functional endothelium to respond to the amplified nitric oxide signal. Conversely, worsening metabolic control can erode what the drug can do.

Lifestyle modifications like regular exercise and weight loss, which improve insulin sensitivity and vascular health independently, also tend to improve erectile function on their own and may enhance the response to sildenafil. This is not a reason to skip the pill and rely on diet and exercise alone, nor a reason to rely on the pill and skip lifestyle changes. For many men with type 2 diabetes, the best results come from combining both. Although the mechanisms behind diabetic ED are complex and multi-layered, the reversible components respond to the same interventions that improve metabolic health generally.¹

If you have type 2 diabetes and are experiencing erectile difficulties, sildenafil is a reasonable and evidence-backed first option to discuss with your physician. The drug’s imperfect performance in this population is not a reason to avoid it; it is a reason to use it thoughtfully, optimize the factors you can control, and consider dose adjustments or alternative approaches if the initial response falls short.